Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission

Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission

Nanoparticles exhibiting the localized surface plasmon resonance (LSPR) phenomenon are promising tools for diagnostics and cancer treatment. Among widely used metal nanoparticles, silver nanoparticles (Ag NPs) possess the strongest light scattering and surface plasmon strength. However, the therapeu...

Full description

Bibliographic Details
Main Authors:	Victoria O. Shipunova, Mariia M. Belova, Polina A. Kotelnikova, Olga N. Shilova, Aziz B. Mirkasymov, Natalia V. Danilova, Elena N. Komedchikova, Rachela Popovtzer, Sergey M. Deyev, Maxim P. Nikitin
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Pharmaceutics
Subjects:	silver nanoparticles photothermal therapy local hyperthermia targeted delivery HER2 affibody
Online Access:	https://www.mdpi.com/1999-4923/14/5/1013

Similar Items

PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death
by: Victoria Olegovna Shipunova, et al.
Published: (2021-06-01)

Albumin incorporation into recognising layer of HER2-specific magnetic nanoparticles as a tool for optimal targeting of the acidic tumor microenvironment
by: Olga A. Kolesnikova, et al.
Published: (2024-07-01)

Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
by: Mohamed Altai, et al.
Published: (2018-10-01)

Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo
by: Victoria O. Shipunova, et al.
Published: (2021-12-01)

Designing, docking and heterologous expression of an anti-HER2 affibody molecule
by: N. Salmanian Tabasi, et al.
Published: (2018-02-01)

Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells
by: Isabella Damiani, et al.
Published: (2021-08-01)

Targeted PLGA–Chitosan Nanoparticles for NIR-Triggered Phototherapy and Imaging of HER2-Positive Tumors
by: Polina A. Kotelnikova, et al.
Published: (2023-12-01)

Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
by: Nina Eissler, et al.
Published: (2024-05-01)

Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents
by: Vera L. Kovalenko, et al.
Published: (2023-08-01)

Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells
by: Elena N. Komedchikova, et al.
Published: (2022-12-01)

Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule <sup>188</sup>Re-ZHER2:41071
by: Yongsheng Liu, et al.
Published: (2022-05-01)

Application of a Novel 68Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients
by: Haitao Miao, et al.
Published: (2022-05-01)

Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
by: Ali Alhuseinalkhudhur, et al.
Published: (2020-03-01)

Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle
by: Zhang C, et al.
Published: (2020-02-01)

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model
by: Charles Dahlsson Leitao, et al.
Published: (2020-06-01)

HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution
by: Haozhong Ding, et al.
Published: (2020-04-01)

Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy
by: Victoria O. Shipunova, et al.
Published: (2023-03-01)

Photothermal Therapy for the Treatment of Glioblastoma: Potential and Preclinical Challenges
by: Chiara Bastiancich, et al.
Published: (2021-01-01)

CuS@BSA-NB2 Nanoparticles for HER2-Targeted Photothermal Therapy
by: Ming Ying, et al.
Published: (2022-01-01)

The Combined Effect of Nanobubble-IR783-HPPH-Affibody Complex and Laser on HER2-Positive Breast Cancer
by: Cai W, et al.
Published: (2023-01-01)

Gold nanorods as photothermal agents and autofluorescence enhancer to track cell death during plasmonic photothermal therapy
by: Kannadorai, Ravi Kumar, et al.
Published: (2015)

Ingenious designed a HER2-Specific macrophage biomimetic multifunctional nanoplatform for enhanced bio-photothermal synergistic therapy in HER2 positive breast cancer
by: Peng Yang, et al.
Published: (2024-06-01)

Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
by: Xianwen Hu, et al.
Published: (2022-06-01)

The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy
by: Wen Yin, et al.
Published: (2021-11-01)

Polypyrrole-Coated Magnetite Vortex Nanoring for Hyperthermia-Boosted Photothermal/Magnetothermal Tumor Ablation Under Photoacoustic/Magnetic Resonance Guidance
by: Jianfeng Bao, et al.
Published: (2021-07-01)

Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy
by: Haijun Wang, et al.
Published: (2021-05-01)

Applications of Inorganic Nanomaterials in Photothermal Therapy Based on Combinational Cancer Treatment
by: Wang J, et al.
Published: (2020-03-01)

Gold Nanostars Embedded in PDMS Films: A Photothermal Material for Antibacterial Applications
by: Gemma Toci, et al.
Published: (2021-11-01)

Synthesis and encapsulation of iron oxide nanorods for application in magnetic hyperthermia and photothermal therapy
by: Mona Lijo P., et al.
Published: (2021-12-01)

The morpho-functional assessment of plasmonic photothermal therapy effects on transplanted liver tumor
by: A. B. Bucharskaya, et al.
Published: (2015-05-01)

Dual functions of gold nanorods as photothermal agent and autofluorescence enhancer to track cell death during plasmonic photothermal therapy
by: Kannadorai, Ravi Kumar, et al.
Published: (2016)

Evaluation of chicken chorioallantoic membrane model for tumor imaging and drug development: Promising findings
by: Lizhen Wang, et al.
Published: (2025-02-01)

In-vitro Study of Photothermal Anticancer Activity of Carboxylated Multiwalled Carbon Nanotubes
by: Bahreyni-Toosi M. H., et al.
Published: (2017-12-01)

Photothermal Hyperthermia Study of Ag/Ni and Ag/Fe Plasmonic Particles Synthesized Using Dual-Pulsed Laser
by: Imran Ali, et al.
Published: (2023-02-01)

Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
by: Tianqi Xu, et al.
Published: (2022-02-01)

Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
by: Yasaman Ardeshirpour, et al.
Published: (2018-04-01)

Development of theranostic dual-layered Au-liposome for effective tumor targeting and photothermal therapy
by: Miyeon Jeon, et al.
Published: (2021-09-01)

Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
by: Haozhong Ding, et al.
Published: (2021-03-01)

Recent Advances in Gold Nanomaterials for Photothermal Therapy
by: Yao-Chen Chuang, et al.
Published: (2022-06-01)

Fractionated photothermal therapy in a murine tumor model: comparison with single dose
by: Simón M, et al.
Published: (2019-07-01)